CLF065, a long-acting, once-weekly GLP-2 receptor agonist, advances in two inflammatory bowel disease indications. The studies aim to bring a regenerative treatment option to patients living with IBD, ...
ReproNovo, a clinical-stage biopharmaceutical company committed to addressing critical gaps in male and female fertility as ...
As Marvel Studios continues to move forward in its 2026 slate, the franchise shows no signs of slowing down before the end of Phase 6. The release of Spider-Man: Brand New Day's first trailer gave ...
The X-65 Active Flow Control demonstrator continues to make progress, with the fuselage now mated with its wing as the first flight remains planned for 2027. The assembly of the Active Flow Control ...
Two webcast auctions offer surplus advanced manufacturing and lab equipment from NFW, including a 2022 IPCO double belt press in July and Oct 2026.